Valanafusp alfa, CAS 1815583-32-4

Product Description: Valanafusp alfa (AGT-181) is a brain penetrating recombinant fusion protein of a chimeric monoclonal antibody against the human insulin receptor (HIR) and human iduronidase (IDUA). Valanafusp alfa can be used for the research of Mucopolysaccharidosis type I (MPS I) [1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Boado RJ, et al. AGT-181: expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys. J Biotechnol. 2009 Oct 26;144(2):135-41./[2]Boado RJ, et al. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier. Biotechnol Bioeng. 2008 Feb 1;99(2):475-84.

CAS Number: 1815583-32-4

Molecular Weight: N/A

Compound Purity: 98.42

Research Area: Metabolic Disease

Solubility: H2O

Target: Insulin Receptor

• Artikelnummer: MEXHY-P99530-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99530-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated